Takeda raises forecasts as it fights off Actos slump | PharmaBoardroom

Takeda raises forecasts as it fights off Actos slump

face
TAGS: ,

Takeda, Asia's largest pharma firm, expects full-year operating profit to increase by 8% to JPY150bn ($1.47bn) as recently implemented cost-efficiency measures kick in and new products boost sales figures.

Latest Report